Theodoros N. Teknos, MD
Theodoros N. Teknos, MD
President and Scientific Director, University Hospitals Seidman Cancer Center
Jane and Lee Seidman Chair in Cancer Innovation
Theodoros (Ted) N. Teknos, MD, is President & Scientific Director for the University Hospitals Seidman Cancer Center at University Hospitals Cleveland Medical Center and Deputy Director of the Case Comprehensive Cancer Center. Dr. Teknos also has been appointed the Jane and Lee Seidman Chair in Cancer Innovation. He is board certified in Otolaryngology‐Head and Neck Surgery. In November 2020 he was bestowed with the Distinguished Physician designation in recognition of exceptional service that personifies UH’s mission: To Heal. To Teach. To Discover.
In his role as President & Scientific Director, Dr. Teknos leads the development of strategic, business and marketing plans for UH Seidman, including cancer‐related palliative care, integrative care and interface with UH Hospice care. He oversees all inpatient and ambulatory cancer care delivered at facilities across the UH system. Dr. Teknos provides leadership of UH Seidman’s academic components and the Clinical Trials Unit and directs UH Seidman’s involvement in the Case Comprehensive Cancer Center.
Dr. Teknos is a renowned clinician and academic authority in head and neck cancers, and he continues his surgical practice, clinical trials and research here at UH. Dr. Teknos has been published in over 200 peer‐reviewed journals and publications, and he is a frequent presenter at major scientific meetings. He is active in numerous professional societies, including the American Society of Clinical Oncology, the International Academy of Oral Oncology, the American Association for Cancer Research, and the American College of Surgeons.
Dr. Teknos came to University Hospitals in October 2017 from The Ohio State University Wexner Medical Center, where he served in several leadership roles since 2008. He served as Professor and Chair, Department of Otolaryngology – Head and Neck Surgery. Prior to his position at Ohio State, he was Division Chief, Head & Neck Oncology Division, Department of Otolaryngology, at the University of Michigan Health System in Ann Arbor. From 2007 to 2014, Dr. Teknos co‐chaired a Task Force on Recurrent & Metastatic Disease for the National Cancer Institute’s Head & Neck Cancer Steering Committee.
Dr. Teknos earned his medical degree from Harvard Medical School. He completed his otolaryngology residency at Massachusetts Eye & Ear Infirmary/Harvard Combined Program, Boston, and a fellowship in head and neck oncology, skull base and microvascular reconstruction at Vanderbilt University Medical Center in Nashville.